PRRT2 Regulates Synaptic Fusion by Directly Modulating SNARE Complex Assembly.

Autor:	Coleman J; Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06520, USA., Jouannot O; Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06520, USA., Ramakrishnan SK; Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06520, USA., Zanetti MN; Department of Clinical and Experimental Epilepsy, University College London, London WC1N 3BG, UK., Wang J; Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06520, USA., Salpietro V; Department of Molecular Neuroscience, Institute of Neurology, University College London, London WC1N 3BG, UK., Houlden H; Department of Molecular Neuroscience, Institute of Neurology, University College London, London WC1N 3BG, UK., Rothman JE; Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Clinical and Experimental Epilepsy, University College London, London WC1N 3BG, UK. Electronic address: james.rothman@yale.edu., Krishnakumar SS; Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Clinical and Experimental Epilepsy, University College London, London WC1N 3BG, UK. Electronic address: shyam.krishnakumar@yale.edu.
Jazyk:	angličtina
Zdroj:	Cell reports [Cell Rep] 2018 Jan 16; Vol. 22 (3), pp. 820-831.
DOI:	10.1016/j.celrep.2017.12.056
Abstrakt:	Mutations in proline-rich transmembrane protein 2 (PRRT2) are associated with a range of paroxysmal neurological disorders. PRRT2 predominantly localizes to the pre-synaptic terminals and is believed to regulate neurotransmitter release. However, the mechanism of action is unclear. Here, we use reconstituted single vesicle and bulk fusion assays, combined with live cell imaging of single exocytotic events in PC12 cells and biophysical analysis, to delineate the physiological role of PRRT2. We report that PRRT2 selectively blocks the trans SNARE complex assembly and thus negatively regulates synaptic vesicle priming. This inhibition is actualized via weak interactions of the N-terminal proline-rich domain with the synaptic SNARE proteins. Furthermore, we demonstrate that paroxysmal dyskinesia-associated mutations in PRRT2 disrupt this SNARE-modulatory function and with efficiencies corresponding to the severity of the disease phenotype. Our findings provide insights into the molecular mechanisms through which loss-of-function mutations in PRRT2 result in paroxysmal neurological disorders. (Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu